Fake vax manufacturer Johnson & Johnson makes feminine hygiene products also, someone needs to put some tampons and maxi pads under the microscope and look for suspicious materials embedded within them!
2002 The University of Texas at Austin bioweapon research study that confirms the lethality and dangers of taking the Covid vaccine.
Severe acute respiratory syndrome (SARS) emerged in China in 2002 and spread to other countries before brought under control. Because of a concern for reemergence or a deliberate release of the SARS coronavirus, vaccine development was initiated. Evaluations of an inactivated whole virus vaccine in ferrets and nonhuman primates and a virus-like-particle vaccine in mice induced protection against infection but challenged animals exhibited an immunopathologic-type lung disease.
Four candidate vaccines for humans with or without alum adjuvant were evaluated in a mouse model of SARS, a VLP vaccine, the vaccine given to ferrets and NHP, another whole virus vaccine and an rDNA-produced S protein. Balb/c or C57BL/6 mice were vaccinated IM on day 0 and 28 and sacrificed for serum antibody measurements or challenged with live virus on day 56. On day 58, challenged mice were sacrificed and lungs obtained for virus and histopathology.
All vaccines induced serum neutralizing antibody with increasing dosages and/or alum significantly increasing responses. Significant reductions of SARS-CoV two days after challenge was seen for all vaccines and prior live SARS-CoV. All mice exhibited histopathologic changes in lungs two days after challenge including all animals vaccinated (Balb/C and C57BL/6) or given live virus, influenza vaccine, or PBS suggesting infection occurred in all. Histopathology seen in animals given one of the SARS-CoV vaccines was uniformly a Th2-type immunopathology with prominent eosinophil infiltration, confirmed with special eosinophil stains. The pathologic changes seen in all control groups lacked the eosinophil prominence.
These SARS-CoV vaccines all induced antibody and protection against infection with SARS-CoV. However, challenge of mice given any of the vaccines led to occurrence of Th2-type immunopathology suggesting hypersensitivity to SARS-CoV components was induced. Caution in proceeding to application of a SARS-CoV vaccine in humans is indicated.
UK -Updated report published 10th June 2021
MHRA Yellow Card Reporting up to 3rd June 2021
Cumulatively 25 weeks for Pfizer, 21 weeks for Astrazeneca and 8 weeks for Moderna
- Pfizer - 14.7million people have received 25.4million doses - Yellowcard reporting rate - 1-in-216 people impacted
- Astrazeneca - 24.5million people have received 40.2million doses - Yellowcare reporting rate - 1-in-125 people impacted
- Moderna - 0.46million people received first dose - Yellowcard reporting rate - 1-in-140 people impacted
Currently overall 1-in-148 people who have received one or both doses of a covid-19 vaccine experiences a Yellow Card Adverse Event.
So, it seems the actual adverse events could easily be 15X of those reported below.
Reactions - 193,768 (Pfizer) + 717,250 (AZ) + 9243 (Moderna) + 2335 (Unknown) = 922,596
Reports - 67,998 (Pfizer) + 195,641 (AZ) + 3278 (Moderna) + 754 (Unknown) = 267,671
Fatal - 406 (Pfizer) + 863 (AZ) + 4 (Moderna) + 22 (Unknown) = 1295
Acute Cardiac - 2479 (Pfizer) + 7494 (AZ) + 61 (Moderna) + 19 (Unknown) = 10,053
Anaphylaxis - 357 (Pfizer) + 723 (AZ) + 11 (Moderna) + 1 (Unknown) = 1092
Blood Disorders - 6715 (Pfizer) + 6311 (AZ) + 174 (Moderna) + 27 (Unknown) = 13,227
Infections - 4839 (Pfizer) + 15,278 (AZ) + 159 (Moderna) + 64 (Unknown) = 20,340
Herpes - 1159 (Pfizer) + 1946 (AZ) + 22 (Moderna) + 11 (Unknown) = 3138
Headaches - 15,992 (Pfizer) + 76,870 (AZ) + 450 (Moderna) + 194 (Unknown) = 93,506
Migraine - 1564 (Pfizer) + 6925 (AZ) + 44 (Moderna) + 21 (Unknown) = 8554
Eye Disorders - 3244 (Pfizer) + 11,480 (AZ) + 98 (Moderna) + 37 (Unknown) = 14,859
Blindness - 41 (Pfizer) + 221 (AZ) + 1 (Moderna) + 2 (Unknown) = 265
Psychiatric Disorders - 3514 (Pfizer) + 14,510 (AZ) + 162 (Moderna) + 56 (Unknown) = 18,242
Skin Disorders - 14,351 (Pfizer) + 43,758 (AZ) + 1870 (Moderna) + 158 (Unknown) = 60,137
Spontaneous Abortions + Stillbirths - 92 + 8 stillbirth/foetal death (Pfizer) + 80 + 4 stillbirth (AZ) + 3 + 1 stillbirth (Moderna) + 1 (Unknown) = 176 + 14
Vomiting - 2238 (Pfizer) + 10,472 (AZ) + 72 (Moderna) + 37 (Unknown) = 12,819
Facial Paralysis incl. Bell’s Palsy - 458 (Pfizer) + 621 (AZ) + 16 (Moderna) + 3 (Unknown) = 1098
Face Swelling - 466 (Pfizer) + 893 (AZ) + 16 (Moderna) + 7 (Unknown) = 1382
Nervous System Disorders - 35,953 (Pfizer) + 154,901 (AZ) + 1349 (Moderna) + 461 (Unknown) = 192,664
Disturbances in Consciousness - 2903 (Pfizer) + 9238 (AZ) + 138 (Moderna) + 37 (Unknown) = 12,316
Strokes and CNS haemorrhages - 372 (Pfizer) + 1537 (AZ) + 6 (Moderna) + 5 (Unknown) = 1920
Guillian Barre Syndrome - 38 (Pfizer) + 283 (AZ) + 1 (Moderna) + 2 (Unknown) = 324
Dizziness - 5514 (Pfizer) + 21,677 (AZ) + 295 (Moderna) + 64 (Unknown) = 27,550
Tremor - 870 (Pfizer) + 9104 (AZ) + 27 (Moderna) + 34 (Unknown) = 10,035
Thrombosis & Embolism (All types) - 704 (Pfizer) + 4227 (AZ) + 10 (Moderna) + 22 (Unknown) = 4963
- Pulmonary Embolism - 229 (Pfizer), 1185 (AZ), 2 (Moderna)
- Deep Vein Thrombosis - 151 (Pfizer), 880 (AZ), 1 (Moderna), 7 (Unknown)
Respiratory Disorders - 8314 (Pfizer) + 23,439 (AZ) + 241 (Moderna) + 72 (Unknown) = 32,066
Nosebleeds - 492 (Pfizer) + 1825 (AZ) + 19 (Moderna) + 6 (Unknown) = 2342
Seizures - 466 (Pfizer) + 1636 (AZ) + 21 (Moderna) + 9 (Unknown) = 2132
Paralysis - 180 (Pfizer) + 586 (AZ) + 6 (Moderna) + 3 (Unknown) = 775
Haemorrhage (All types) - 826 (Pfizer) + 2702 (AZ) + 62 (Moderna) + 10 (Unknown) = 3600
- Haemorrhage types - cardiac, ear, adrenal, eye, gastric, mouth, tongue, gums, intestinal, injection site, brain, wounds, stoma, bladder, kidney, vaginal, uterine, post-menopausal bleeding, ovarian, penile, lung, nasal
Vertigo/Tinnitis - 1692 (Pfizer) + 4916 (AZ) + 90 (Moderna) + 18 (Unknown) = 6716
Reproductive/Breast - 2777 (Pfizer) + 6454 (AZ) + 277 (Moderna) + 27 (Unknown) = 9535
Thanks Jenny for the hard work compiling this.
VERY IMPORTANT MESSAGE - BREES MEDIA: 11TH JUNE 2021 DR ROGER HODKINSON
CDC PLANS “EMERGENCY MEETING” ON RARE HEART INFLAMMATION FOLLOWING COVID-19 VACCINES
Next week, the Centers for Disease Control is holding an emergency meeting of its advisers. The group known as ACIP will discuss reports of a rare heart issue cropping up in adolescents and young adults.
The condition is known as myocarditis. It’s an inflammation of the heart muscle, usually caused by a virus.
The inflammation enlarges and weakens the heart and can create scar tissue. That makes it harder for the heart to pump blood and oxygen throughout the body. Another condition is also being reported: pericarditis. This is an inflammation of the other lining of the heart. The CDC said that, in both cases, the body’s immune system is causing inflammation in response to an infection or some other trigger.
Federal health officials have identified 226 reports in young individuals after receiving a Pfizer or Moderna COVID-19 vaccination.
Experts expected some cases would occur but these are at much higher rates than what was projected. Officials reported that the problem occurred most after the second dose and was overwhelmingly detected in males.
The Chilean health authorities reported this Monday that they will ban second doses of the AstraZeneca COVID-19 vaccine in men under 45 years of age, who will receive Pfizer to finalize their immunization starting this week.
“For the (men) under 45 years of age who have already received a dose of AstraZeneca, it was determined that they complete their vaccination with Pfizer,” said the Undersecretary of Health, Paula Daza.